1
|
Sumi R, Miyake A, Endo T, Ohsato Y, Ngo MH, Nishigaki K. Polymerase chain reaction-based detection of myc transduction in feline leukemia virus-infected cats. Arch Virol 2018; 163:1073-1077. [PMID: 29353423 DOI: 10.1007/s00705-018-3721-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Accepted: 12/13/2017] [Indexed: 12/28/2022]
Abstract
Feline lymphomas are associated with the transduction and activation of cellular proto-oncogenes, such as c-myc, by feline leukemia virus (FeLV). We describe a polymerase chain reaction assay for detection of myc transduction usable in clinical diagnosis. The assay targets c-myc exons 2 and 3, which together result in a FeLV-specific fusion gene following c-myc transduction. When this assay was conducted on FeLV-infected feline tissues submitted for clinical diagnosis of tumors, myc transduction was detected in 14% of T-cell lymphoma/leukemias. This newly established system could become a useful diagnostic tool in veterinary medicine.
Collapse
Affiliation(s)
- Ryosuke Sumi
- Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan
| | - Ariko Miyake
- Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan
| | - Taiji Endo
- Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan
| | | | - Minh Ha Ngo
- The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan
| | - Kazuo Nishigaki
- Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan. .,The United Graduate School of Veterinary Science, Yamaguchi University, 1677-1 Yoshida, Yamaguchi, 753-8515, Japan.
| |
Collapse
|
2
|
Beatty J. Viral causes of feline lymphoma: Retroviruses and beyond. Vet J 2014; 201:174-80. [DOI: 10.1016/j.tvjl.2014.05.026] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2013] [Revised: 05/11/2014] [Accepted: 05/17/2014] [Indexed: 11/30/2022]
|
3
|
Ahmad S, Levy LS. The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945. Virology 2010; 403:103-10. [PMID: 20451235 DOI: 10.1016/j.virol.2010.04.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2010] [Revised: 02/22/2010] [Accepted: 04/12/2010] [Indexed: 12/24/2022]
Abstract
During feline leukemia virus (FeLV) infection in the domestic cat, viruses with a novel envelope gene arise by recombination between endogenous FeLV-related elements and the exogenous infecting species. These recombinant viruses (FeLV-B) are of uncertain disease association, but have been linked to the induction of thymic lymphoma. To assess the role of FeLV-B in the induction of multicentric lymphoma and other non-T-cell disease, the frequency of occurrence and nature of FeLV-B were examined in diseased tissues from a large collection of FeLV-infected animals. Diseased tissues were examined by Southern blot and PCR amplification to detect the presence of FeLV-B. Further analysis was performed to establish the recombination junctions and infectivity of FeLV-B in diseased tissues. The results confirmed the frequent association of FeLV-B with thymic lymphoma but showed infrequent generation, low levels and lack of infectivity of FeLV-B in non-T-cell diseases including multicentric lymphoma.
Collapse
Affiliation(s)
- Shamim Ahmad
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
| | | |
Collapse
|
4
|
Fujino Y, Ohno K, Tsujimoto H. Molecular pathogenesis of feline leukemia virus-induced malignancies: Insertional mutagenesis. Vet Immunol Immunopathol 2008; 123:138-43. [DOI: 10.1016/j.vetimm.2008.01.019] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Rohn JL, Lauring AS, Linenberger ML, Overbaugh J. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J Virol 1996; 70:8071-80. [PMID: 8892932 PMCID: PMC190881 DOI: 10.1128/jvi.70.11.8071-8080.1996] [Citation(s) in RCA: 91] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Feline leukemia virus (FeLV) is thought to induce neoplastic diseases in infected cats by a variety of mechanisms, including the transduction of host proto-oncogenes. While FeLV recombinants that encode cellular sequences have been isolated from tumors of naturally infected animals, the acquisition of an unrelated host gene has never been documented in an experimental FeLV infection. We isolated recombinant FeLV proviruses encoding feline Notch2 sequences from thymic lymphoma DNA of two cats inoculated with the molecularly cloned virus FeLV-61E. Four recombinant genomes were identified, three in one cat and one in the other. Each had similar but distinct transduction junctions, and in all cases, the insertions replaced most of the envelope gene with a region of Notch2 that included the intracellular ankyrin repeat functional domain. The product of the FeLV/Notch2 recombinant provirus was a novel, truncated 65- to 70-kD Notch2 protein that was targeted to the cell nucleus. This virally encoded Notch2 protein, which resembles previously constructed, constitutively activated forms of Notch, was apparently expressed from a subgenomic transcript spliced at the normal envelope donor and acceptor sequences. The data reported here implicate a nuclear, activated Notch2 protein in FeLV-induced leukemogenesis.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Base Sequence
- Cat Diseases/virology
- Cats
- Cell Line
- Cloning, Molecular
- DNA, Viral
- Gene Rearrangement
- Genome, Viral
- Leukemia Virus, Feline/genetics
- Lymphoma/veterinary
- Lymphoma/virology
- Molecular Sequence Data
- Proviruses
- RNA, Viral/analysis
- Rats
- Receptor, Notch2
- Receptors, Antigen, T-Cell, alpha-beta/genetics
- Receptors, Cell Surface/genetics
- Recombination, Genetic
- Retroviridae Infections/veterinary
- Retroviridae Infections/virology
- Sequence Homology, Amino Acid
- Sequence Homology, Nucleic Acid
- Thymus Neoplasms/veterinary
- Thymus Neoplasms/virology
- Transfection
- Tumor Virus Infections/veterinary
- Tumor Virus Infections/virology
Collapse
Affiliation(s)
- J L Rohn
- Department of Microbiology, University of Washington, Seattle 98195, USA
| | | | | | | |
Collapse
|
6
|
Starkey CR, Levy LS. Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system. Int J Cancer 1995; 62:325-31. [PMID: 7628875 DOI: 10.1002/ijc.2910620316] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
The molecular events characterizing lymphoid malignancy have been examined in an animal model system, specifically, the retroviral induction of leukemia and lymphoma in the domestic cat following infection with feline leukemia virus (FeLV). Genes differentially expressed in FeLV-induced lymphomas were isolated using a strategy of differential hybridization. Six genes were identified which demonstrate a higher level of expression in an FeLV-induced feline thymic tumor as compared with normal thymus. The differentially expressed genes encode the feline homologues of ribosomal proteins S3a, S4, S17, and L41, elongation factor-1 alpha, and cytochrome oxidase sub-unit I. Northern-blot analysis and quantification by phosphorimaging demonstrates that these genes are expressed at levels from 1.5- to 3.1-fold higher in J5-1 thymic tumor as compared with normal thymus. Expression of the selected ribosomal protein mRNA was further examined in a series of human and feline tissues, including normal tissues, malignant tumors and cell lines. Our data reveal that elevation of the selected ribosomal protein mRNA is associated with all FeLV-induced thymic lymphomas examined. The differentially expressed ribosomal protein mRNA accumulates in a balanced manner in thymic lymphomas. By contrast, the elevation in ribosomal protein mRNA levels is not associated uniformly with hematopoietic malignancy. T-lymphoid malignancy, solid tumors or actively proliferating cells. Rather, the elevation appears to be a uniform and distinctive feature of T-cell malignancy of this particular type. The elevated expression of these genes may be causally related to the neoplastic process.
Collapse
MESH Headings
- Adult
- Animals
- Blotting, Northern
- Cats
- DNA, Neoplasm/analysis
- DNA, Neoplasm/genetics
- Disease Models, Animal
- Electron Transport Complex IV/genetics
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Leukemia Virus, Feline
- Leukemia, T-Cell/genetics
- Leukemia, T-Cell/virology
- Lymphoma, T-Cell/genetics
- Lymphoma, T-Cell/virology
- Male
- Oncogenes
- Peptide Elongation Factor 1
- Peptide Elongation Factors/genetics
- RNA, Messenger/analysis
- Ribosomal Proteins/genetics
- Thymus Neoplasms/genetics
- Tumor Cells, Cultured
Collapse
Affiliation(s)
- C R Starkey
- Program in Molecular and Cellular Biology, Tulane Medical School, New Orleans, LA, USA
| | | |
Collapse
|
7
|
Linenberger ML, Abkowitz JL. Haematological disorders associated with feline retrovirus infections. BAILLIERE'S CLINICAL HAEMATOLOGY 1995; 8:73-112. [PMID: 7663052 PMCID: PMC7135792 DOI: 10.1016/s0950-3536(05)80233-1] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Feline oncornavirus and lentivirus infections have provided useful models to characterize the virus and host cell factors involved in a variety of marrow suppressive disorders and haematological malignancies. Exciting recent progress has been made in the characterization of the viral genotypic features involved in FeLV-associated diseases. Molecular studies have clearly defined the causal role of variant FeLV env gene determinants in two disorders: the T-lymphocyte cytopathicity and the clinical acute immunosuppression induced by the FeLV-FAIDS variant and the pure red cell aplasia induced by FeLV-C/Sarma. Variant or enFeLV env sequences also appear to play a role in FeLV-associated lymphomas. Additional studies are required to determine the host cell processes that are perturbed by these variant env gene products. In the case of the FeLV-FAIDS variant, the aberrant env gene products appear to impair superinfection interference, resulting in accumulation of unintegrated viral DNA and cell death. In other cases it is likely that the viral env proteins interact with host products that are important in cell viability and/or proliferation. Understanding of these mechanisms will therefore provide insights to factors involved in normal lymphohaematopoiesis. Similarly, studies of FeLV-induced haematological neoplasms should reveal recombination or rearrangement events involving as yet unidentified host gene sequences that encode products involved in normal cell growth regulation. These sequences may include novel protoncogenes or sequences homologous to genes implicated in human haematological malignancies. The haematological consequences of FIV are quite similar to those associated with HIV. As with HIV, FIV does not appear to directly infect myeloid or erythroid precursors, and the mechanisms of marrow suppression likely involve virus, viral antigen, and/or infected accessory cells in the marrow microenvironment. Studies using in vitro experimental models are required to define the effects of each of these microenvironmental elements on haematopoietic progenitors. As little is known about the molecular mechanisms of FIV pathogenesis, additional studies of disease-inducing FIV strains are needed to identify the genotypic features that correlate with virulent phenotypic features. Finally, experimental FIV infection in cats provides the opportunity to correlate in vivo virological and haematological changes with in vitro observations in a large animal model that closely mimics HIV infection in man.
Collapse
MESH Headings
- Animals
- Antibodies, Viral/biosynthesis
- Antibodies, Viral/immunology
- Bone Marrow/pathology
- Bone Marrow/virology
- Cats/virology
- Feline Acquired Immunodeficiency Syndrome/immunology
- Feline Acquired Immunodeficiency Syndrome/transmission
- Genes, Viral
- Immunity, Cellular
- Immunodeficiency Virus, Feline/genetics
- Immunodeficiency Virus, Feline/immunology
- Immunodeficiency Virus, Feline/physiology
- Leukemia Virus, Feline/classification
- Leukemia Virus, Feline/genetics
- Leukemia Virus, Feline/immunology
- Leukemia Virus, Feline/physiology
- Leukemia, Feline/immunology
- Leukemia, Feline/transmission
- Lymphoma/epidemiology
- Lymphoma/veterinary
- Lymphoma/virology
- Myelodysplastic Syndromes/veterinary
- Myelodysplastic Syndromes/virology
- Red-Cell Aplasia, Pure/veterinary
- Red-Cell Aplasia, Pure/virology
- Retroviridae/classification
- Retroviridae Proteins/genetics
- Retroviridae Proteins/physiology
- Spumavirus/pathogenicity
Collapse
Affiliation(s)
- M L Linenberger
- Department of Medicine, University of Washington, Seattle 98195, USA
| | | |
Collapse
|
8
|
Tsatsanis C, Fulton R, Nishigaki K, Tsujimoto H, Levy L, Terry A, Spandidos D, Onions D, Neil JC. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol 1994; 68:8296-303. [PMID: 7966623 PMCID: PMC237298 DOI: 10.1128/jvi.68.12.8296-8303.1994] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
The genetic basis of feline leukemia virus (FeLV)-induced lymphoma was investigated in a series of 63 lymphoid tumors and tumor cell lines of presumptive T-cell origin. These were examined for virus-induced rearrangements of the c-myc, flvi-2 (bmi-1), fit-1, and pim-1 loci, for T-cell receptor (TCR) gene rearrangements, and for the presence of env recombinant FeLV (FeLV-B). The myc locus was most frequently affected in naturally occurring lymphomas (32%; n = 38) either by transduction (21%) or by proviral insertion (11%). Proviral insertions were also common at flvi-2 (24%). The two other loci were occupied in a smaller number of the naturally occurring tumors (fit-1, 8%; pim-1, 5%). Examination of the entire set of tumors showed that significant numbers were affected at two (19%) or three (5%) of the loci. Occupation of the fit-1 locus was observed most frequently in tumors induced by FeLV-myc strains, while flvi-2 insertions occurred with similar frequency in the presence or absence of obvious c-myc activation. These results suggest a hierarchy of mutational events in the genesis of feline T-cell lymphomas by FeLV and implicate insertion at fit-1 as a late progression step. The strongest links observed were with T-cell development, as monitored by rearrangement status of the TCR beta-chain gene, which was positively associated with activation of myc (P < 0.001), and with proviral insertion at flvi-2 (P = 0.02). This analysis also revealed a genetically distinct subset of thymic lymphomas with unrearranged TCR beta-chain genes in which the known target loci were involved very infrequently. The presence of env recombinant FeLV (FeLV-B) showed a negative correlation with proviral insertion at fit-1, possibly due to the rapid onset of these tumors. These results shed further light on the multistep process of FeLV leukemogenesis and the relationships between lymphoid cell maturation and susceptibility to FeLV transformation.
Collapse
Affiliation(s)
- C Tsatsanis
- Department of Veterinary Pathology, University of Glasgow, Bearsden, Scotland
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Terry A, Fulton R, Stewart M, Onions DE, Neil JC. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors. J Virol 1992; 66:3538-49. [PMID: 1316466 PMCID: PMC241135 DOI: 10.1128/jvi.66.6.3538-3549.1992] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
A naturally occurring feline thymic lymphosarcoma (T17) provided the unique observation of a T-cell antigen receptor beta-chain gene (v-tcr) transduced by a retrovirus. The primary tumor contained three classes of feline leukemia virus (FeLV) provirus, which have now been characterized in more detail as (i) v-tcr-containing recombinant proviruses, (ii) v-myc-containing recombinant proviruses, and (iii) apparently full-length helper FeLV proviruses. The two transductions appear to have been independent events, with distinct recombinational junctions and no sequence overlap in the host-derived inserts. The T17 tumor cell line releases large numbers of FeLV particles of low infectivity; all three genomes are encapsidated, but passage of FeLV-T17 on feline fibroblast and lymphoma cells led to selective loss of the recombinant viruses. The oncogenic potential of the T17 virus complex was, therefore, tested by infection of neonatal cats with virus harvested directly from the primary T17 tumor cell line. A single inoculation of FeLV-T17 caused persistent low-grade infection culminating in thymic lymphosarcoma and acute thymic atrophy, which was accelerated by coinfection with the weakly pathogenic FeLV subgroup A (FeLV-A)/Glasgow-1 helper. Molecularly cloned FeLV-tcr virus (T-31) rescued for replication by a weakly pathogenic FeLV-A/Glasgow-1 helper virus was similarly tested in vivo and induced thymic atrophy and thymic lymphosarcomas. Most FeLV-T17-induced tumors manifested either v-myc or an activated c-myc allele and had undergone rearrangement of endogenous T-cell antigen receptor beta-chain genes, supporting the proposition that the oncogenic effects of c-myc linked to the FeLV long terminal repeat are targeted to a specific window in T-cell differentiation. However, neither the FeLV-T17-induced tumors nor the T-31 + FeLV-A-induced tumors contained clonally represented v-tcr sequences. Only one of the FeLV-T17-induced tumors contained detectable v-tcr proviruses, at a low copy number. While v-tcr does not have a readily transmissible oncogenic function, a more restricted role is not excluded, perhaps involving antigenic peptide-major histocompatibility complex recognition by the T-cell receptor complex. Such a function could be obscured by the genetic diversity of the outbred domestic cat host.
Collapse
MESH Headings
- Animals
- Atrophy
- Base Sequence
- Cats
- Cells, Cultured
- Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
- Genes, myc
- Helper Viruses
- Leukemia Virus, Feline/genetics
- Leukemia Virus, Feline/pathogenicity
- Lymphoma, Non-Hodgkin/microbiology
- Molecular Sequence Data
- Proviruses/genetics
- Proviruses/pathogenicity
- Receptors, Antigen, T-Cell, alpha-beta/genetics
- Sequence Homology, Nucleic Acid
- Serial Passage
- Thymus Gland/pathology
- Thymus Neoplasms/microbiology
- Transduction, Genetic/genetics
- Tumor Virus Infections/genetics
- Tumor Virus Infections/pathology
Collapse
Affiliation(s)
- A Terry
- Beatson Institute for Cancer Research, Cancer Research Campaign Beatson Laboratories, Bearsden, Glasgow
| | | | | | | | | |
Collapse
|
10
|
Levy LS, Lobelle-Rich PA. Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus. J Virol 1992; 66:2885-92. [PMID: 1313907 PMCID: PMC241047 DOI: 10.1128/jvi.66.5.2885-2892.1992] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
LC-FeLV is a myc-containing strain of feline leukemia virus (FeLV) which exhibits only partial transforming activity in vitro and in vivo. LC-FeLV infection in kittens may induce, but does not necessarily induce, thymic lymphosarcoma in viremic animals after a short latency. These observations suggest that infection with LC-FeLV is not sufficient to induce complete transformation and that another genetic event(s) is required. One possibility for such an event is that the integrating provirus acts as an insertional mutagen and thereby disrupts the structure or function of another proto-oncogene. Using a strategy of transposon tagging, this possibility was examined in eight feline T-cell lymphosarcomas, including four induced by experimental infection with LC-FeLV, three induced by natural infection with FeLV, and one FeLV-negative tumor. The analysis demonstrated one locus, termed flvi-2, to be structurally altered in six of the tumors examined, including three induced by LC-FeLV and three in which no activated myc oncogene is apparent. Inverse polymerase chain reaction was used to demonstrate the presence and transcriptional orientation of proviruses integrated at flvi-2 in five of these tumors. The flvi-2 locus does not hybridize to cloned probes representing 21 previously identified proto-oncogenes or common domains of retroviral integration. Thus, the data suggest that interruption of the flvi-2 locus cooperates with the myc oncogene in the induction of T-cell lymphomas by LC-FeLV; indeed, the observations indicate that the insertional mutagenesis of flvi-2 plays a role in T-cell lymphomagenesis even in the absence of feline v-myc.
Collapse
MESH Headings
- Animals
- Blotting, Southern
- Cats
- Cell Transformation, Neoplastic/genetics
- Cloning, Molecular
- DNA, Neoplasm/genetics
- Genes, myc/genetics
- Leukemia Virus, Feline/genetics
- Leukemia Virus, Feline/pathogenicity
- Lymphoma, Non-Hodgkin/genetics
- Molecular Sequence Data
- Mutagenesis, Insertional/genetics
- Neoplasms, Experimental/genetics
- Proviruses/genetics
- Restriction Mapping
- Thymus Neoplasms/genetics
- Virus Integration/genetics
Collapse
Affiliation(s)
- L S Levy
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112-2699
| | | |
Collapse
|
11
|
Affiliation(s)
- L J Rezanka
- Department of Veterinary Pathobiology, Ohio State University, Columbus 43210
| | | | | |
Collapse
|
12
|
Neil JC, Fulton R, Rigby M, Stewart M. Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol 1991; 171:67-93. [PMID: 1667630 DOI: 10.1007/978-3-642-76524-7_4] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
MESH Headings
- Amino Acid Sequence
- Anemia/microbiology
- Anemia/veterinary
- Animals
- Base Sequence
- Cat Diseases/microbiology
- Cats/microbiology
- Feline Acquired Immunodeficiency Syndrome/microbiology
- Gene Expression Regulation, Neoplastic
- Gene Expression Regulation, Viral
- Gene Products, env/genetics
- Gene Products, env/physiology
- Genes, env
- Leukemia Virus, Feline/classification
- Leukemia Virus, Feline/genetics
- Leukemia Virus, Feline/pathogenicity
- Leukemia Virus, Feline/physiology
- Leukemia, Feline/microbiology
- Mink Cell Focus-Inducing Viruses/genetics
- Molecular Sequence Data
- Mutagenesis, Insertional
- Oncogenes
- Proto-Oncogenes
- Recombination, Genetic
- Repetitive Sequences, Nucleic Acid
- Transduction, Genetic
- Virulence
- Virus Integration
Collapse
Affiliation(s)
- J C Neil
- Beatson Institute for Cancer Research, Glasgow, UK
| | | | | | | |
Collapse
|
13
|
Levesque KS, Bonham L, Levy LS. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol 1990; 64:3455-62. [PMID: 2161948 PMCID: PMC249607 DOI: 10.1128/jvi.64.7.3455-3462.1990] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
A locus in feline DNA, termed flvi-1, which may play an important role in the natural induction of lymphomas by feline leukemia virus (FeLV) was identified. Examination of a bank of 21 naturally occurring FeLV-positive feline lymphomas revealed that FeLV proviral integration occurs at flvi-1 in four independent tumors (19%). Independent integrations occurred within a 2.4-kilobase region of flvi-1, the probability of which by random chance can be estimated as 10(-16). Several lines of evidence, including sequence analysis of the long terminal repeat, demonstrated that proviruses integrated at flvi-1 are exogenously acquired and are oriented in the same transcriptional direction with respect to the locus. Molecularly cloned flvi-1 did not hybridize with probes representing several previously described proviral integration domains or with probes representing 10 oncogenes. The natural feline lymphomas examined in this study were heterogeneous with respect to tissue of origin, cell type, and number of monoclonal proviral integrations. The four tumors in which flvi-1 is interrupted were classified as members of a phenotypic subgroup containing seven lymphomas, i.e., at least four (57%) of seven lymphomas of this type contained FeLV proviral integration at flvi-1. Members of this phenotypic subgroup are non-T-cell lymphomas isolated from the spleen and contain an average of three proviruses, compared with an average of eight among all of the tumors examined. The small number of proviral integrations in tumors of this subgroup suggests that an early proviral integration event into flvi-1 can induce malignant change.
Collapse
Affiliation(s)
- K S Levesque
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112
| | | | | |
Collapse
|